These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. HIV protease inhibitors: recent clinical trials and recommendations on use. Fernández-Montero JV; Barreiro P; Soriano V Expert Opin Pharmacother; 2009 Jul; 10(10):1615-29. PubMed ID: 19527188 [TBL] [Abstract][Full Text] [Related]
34. Releasing the true power of protease inhibitors. Raffi F Int J STD AIDS; 2003 Oct; 14 Suppl 1():29-33. PubMed ID: 14617401 [TBL] [Abstract][Full Text] [Related]
35. Does atazanavir cause lipodystrophy? Gazzard BG; Moyle G J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875 [TBL] [Abstract][Full Text] [Related]
36. Atazanavir for the treatment of human immunodeficiency virus infection. Busti AJ; Hall RG; Margolis DM Pharmacotherapy; 2004 Dec; 24(12):1732-47. PubMed ID: 15585441 [TBL] [Abstract][Full Text] [Related]
37. Reviving protease inhibitors: new data and more options. Murphy RL J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S43-52; quiz S53, S55-6. PubMed ID: 12946064 [No Abstract] [Full Text] [Related]
38. The cellular pharmacokinetics of HIV protease inhibitors: current knowledge and future perspectives. Zha W; Zha BS; Zhou F; Zhou H; Wang G Curr Drug Metab; 2012 Oct; 13(8):1174-83. PubMed ID: 22746305 [TBL] [Abstract][Full Text] [Related]
39. Atazanavir: the advent of a new generation of more convenient protease inhibitors. Barreiro P; Rendón A; Rodríguez-Nóvoa S; Soriano V HIV Clin Trials; 2005; 6(1):50-61. PubMed ID: 15765311 [TBL] [Abstract][Full Text] [Related]
40. Atazanavir: a review of its use in the management of HIV-1 infection. Croom KF; Dhillon S; Keam SJ Drugs; 2009 May; 69(8):1107-40. PubMed ID: 19496633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]